Montoya GE, Huerta RJF Cázares GLR, Barragán JRL

Language: Spanish
References: 21
Page: 110-113
PDF size: 111.44 Kb.

ABSTRACT

An infant patient with sepsis, candidemia and invasive endocarditis for Candida after a surgery of intestine, is presented. After the treatment failure of amphotericin B, using a colloidal dispersion (5 mg/kg daily), with persistence of the fungus in blood cultures, is treated with caspofungin in doses of 70 mg/m² (CS), as a impregnating doses and later at 50 mg/m² (CS) daily, with a good clinical and microbiological response and remission of the infection.

REFERENCES

1. Ellis E, Al-abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature 1965-1995. Clin Infect Dis 2001; 32(1): 50-62.

2. Brook MM. Pediatric bacterial endocarditis. Ped Clin North Am 1999; 46(2): 275-287.

3. Vallés F, Anguita M, Escribano P, Pérez CF, Pousibet F, Tomos P, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en Endocarditis. Rev Esp Cardiol 2000; 53: 1384-1396.

4. Mecrow K, Ladusans J. Infective endocarditis in newborn infants with structurally normal hearts. Acta Paediatr 1994; 83(1): 35-39.

5. Sternbach L, Bresler J. Cardiovascular infections and mediastinitis. In: Brillman JC, Quenzer RW. editors. Infectious disease in emergency medicine. 2nd Ed. Philadelphia: Raven Press 1998: 521-541.

6. Aspesberro F, Beghetti M, Oberthyansli I, Friedli B. Fungal endocarditis in critically in children. Eur J Pediatr 1999; 158(4): 275-280.

7. Hartyánszky L, Pintér M, Kádár K, Oprea V, Krause I, Lozsádi K. Candida endocarditis in an infant. Pediatr Cardiol 1997; 18(6): 440-442.

8. Rex H, Rinaldi G, Pfaller A. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1-8.

9. Del Castillo M, Wainsztein N, Klein F, Manganello S, Orellana N. Tratamiento con caspofungina de endocarditis por Candida tropicalis resistente a fluconazol. Medicina (Buenos Aires) 2004; 64: 152-154.

10. Keating M, Jarvis B. Caspofungin. Drugs 2001; 61: 1121-1129.

11. Deserinski C, Stevens A. Caspofungin. Clin Infect Dis 2003; 36: 1445-1457.

12. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J et al. Caspofungin invasive candidiasis study group. Comparison of caspofungin and Amphotericin B for invasive candidiasis. N Engl J Med 2002; 347: 2020-2029.

13. Walsh TJ. Echinocandins. An advance in the primary treatment of invasive candidiasis. N Engl J Med 2002; 347: 2070-2072.

14. Varini S. Consenso de Endocarditis Infecciosa. Comisión de diagnóstico y evaluación. Rev Argen Cardiol 2002; 70 (Suppl 5): 8-19.

15. Gallego C, De la Torre J. Actualización diagnóstica y terapéutica en infecciones fúngicas invasoras: de los antiguos tópicos a las nuevas evidencias. Farmacia Hosp (Madrid) 2001; 25(6): 345-355.

16. Pontón J. Diagnóstico microbiológico de las micosis. Rev Iberoam Micol 2002; 19: 25-29.

17. Llinares MP. Endocarditis infecciosa. Medicine 1998; 7(73): 3394-3399.

18. Pappas G, Rex H, Sobel D, Filler G, Dismukes E, Walsh J, et al. Guidelines for treatment of candidiasis. CID 2004; 38: 161-189.

19. De Alarcón A, Gálvez J, Reguera J, Ruiz J, Lomas M. Documento de consenso sobre el tratamiento y profilaxis de la endocarditis infecciosa (monografía en Internet). Sociedad Andaluza de Enfermedades Infecciosas (2005) http://saei.org/hemero/consensos/default.html.

20. Hauser M, Hess J, Belohradsky B. Treatment of Candida albicans endocarditis: Case report and a review. Infection 2003; 2: 125-127.

21. Committee on Infectious Diseases; American Academy of Pediatrics. Antifungal drugs for Systemic fungal Infections. In: Red Book 2006; 27 edition: 774-784.